Similarly, Dutta et al. [137] developed pH-sensitive nanoparticles for pancreatic ductal adenocarcinoma (PDAC), enabling the selective release of the ERK inhibitor SCH772984 in the hypoxic and acidic tumor microenvironment. This evidence concerns the gene MAPK1 and neoplasm.